These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 28552769)
21. About the impact of superassociation of hydrophobic ion pairs on membrane permeability. Shahzadi I; Nazir I; Nhu Quynh Phan T; Bernkop-Schnürch A Eur J Pharm Biopharm; 2020 Jun; 151():1-8. PubMed ID: 32268189 [TBL] [Abstract][Full Text] [Related]
22. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage. Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624 [TBL] [Abstract][Full Text] [Related]
23. Contribution of the paracellular route to the pH-dependent epithelial permeability to cationic drugs. Nagahara N; Tavelin S; Artursson P J Pharm Sci; 2004 Dec; 93(12):2972-84. PubMed ID: 15459946 [TBL] [Abstract][Full Text] [Related]
24. Positively-charged microemulsion for improving the oral bioavailability of alendronate: in-vitro and in-vivo assessment. Meng J; Hu L J Pharm Pharmacol; 2011 Mar; 63(3):400-8. PubMed ID: 21749388 [TBL] [Abstract][Full Text] [Related]
25. Enhanced Oral Delivery of Bisphosphonate by Novel Absorption Enhancers: Improvement of Intestinal Absorption of Alendronate by N-Acyl Amino Acids and N-Acyl Taurates and Their Absorption-Enhancing Mechanisms. Nakaya Y; Takaya M; Hinatsu Y; Alama T; Kusamori K; Katsumi H; Sakane T; Yamamoto A J Pharm Sci; 2016 Dec; 105(12):3680-3690. PubMed ID: 27771051 [TBL] [Abstract][Full Text] [Related]
26. Application of a Human Intestinal Epithelial Cell Monolayer to the Prediction of Oral Drug Absorption in Humans as a Superior Alternative to the Caco-2 Cell Monolayer. Takenaka T; Harada N; Kuze J; Chiba M; Iwao T; Matsunaga T J Pharm Sci; 2016 Feb; 105(2):915-924. PubMed ID: 26869436 [TBL] [Abstract][Full Text] [Related]
27. Ion-pair strategy for enabling amifostine oral absorption: rat in situ and in vivo experiments. Samiei N; Mangas-Sanjuan V; González-Álvarez I; Foroutan M; Shafaati A; Zarghi A; Bermejo M Eur J Pharm Sci; 2013 Jul; 49(4):499-504. PubMed ID: 23643735 [TBL] [Abstract][Full Text] [Related]
28. Artificial membrane assays to assess permeability. Faller B Curr Drug Metab; 2008 Nov; 9(9):886-92. PubMed ID: 18991585 [TBL] [Abstract][Full Text] [Related]
29. High payload nanostructured lipid carriers fabricated with alendronate/polyethyleneimine ion complexes. Abd El-Hamid BN; Swarnakar NK; Soliman GM; Attia MA; Pauletti GM Int J Pharm; 2018 Jan; 535(1-2):148-156. PubMed ID: 29104057 [TBL] [Abstract][Full Text] [Related]
30. Tc-99m Radiolabeled Alendronate Sodium Microemulsion: Characterization and Permeability Studies Across Caco-2 Cells. Elitez Y; Ekinci M; Ilem-Ozdemir D; Gundogdu E; Asikoglu M Curr Drug Deliv; 2018; 15(3):342-350. PubMed ID: 28606033 [TBL] [Abstract][Full Text] [Related]
32. Alendronate-loaded microparticles for improvement of intestinal cellular absorption. Baek JS; Kwon HH; Hwang JS; Sung HC; Lee JM; Shin SC; Kim YR; Cho CW J Drug Target; 2011 Jan; 19(1):37-48. PubMed ID: 20477555 [TBL] [Abstract][Full Text] [Related]
33. Transport mechanisms of flavanone aglycones across Caco-2 cell monolayers and artificial PAMPA membranes. Kobayashi S; Nagai T; Konishi Y; Tanabe S; Morimoto K; Ogihara T J Pharm Pharmacol; 2012 Jan; 64(1):52-60. PubMed ID: 22150672 [TBL] [Abstract][Full Text] [Related]
34. Studies on the formation of hydrophobic ion-pairing complex of alendronate. You SK; Kwon HH; Lee JM; Shin SC; Cho CW Arch Pharm Res; 2009 Jul; 32(7):1055-60. PubMed ID: 19641887 [TBL] [Abstract][Full Text] [Related]
35. PAMPA--a drug absorption in vitro model 11. Matching the in vivo unstirred water layer thickness by individual-well stirring in microtitre plates. Avdeef A; Nielsen PE; Tsinman O Eur J Pharm Sci; 2004 Aug; 22(5):365-74. PubMed ID: 15265506 [TBL] [Abstract][Full Text] [Related]
36. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery. Kerns EH; Di L; Petusky S; Farris M; Ley R; Jupp P J Pharm Sci; 2004 Jun; 93(6):1440-53. PubMed ID: 15124203 [TBL] [Abstract][Full Text] [Related]
37. The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability. Tam KY; Avdeef A; Tsinman O; Sun N J Med Chem; 2010 Jan; 53(1):392-401. PubMed ID: 19947605 [TBL] [Abstract][Full Text] [Related]
38. Mechanisms of membrane transport of poorly soluble drugs: role of micelles in oral absorption processes. Yano K; Masaoka Y; Kataoka M; Sakuma S; Yamashita S J Pharm Sci; 2010 Mar; 99(3):1336-45. PubMed ID: 19743502 [TBL] [Abstract][Full Text] [Related]
39. Ion-pair formation as a strategy to enhance topical delivery of salicylic acid. Megwa SA; Cross SE; Benson HA; Roberts MS J Pharm Pharmacol; 2000 Aug; 52(8):919-28. PubMed ID: 11007062 [TBL] [Abstract][Full Text] [Related]
40. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a). Usansky HH; Sinko PJ J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]